Larimar Therapeutics Inc (LRMR)
2.45 x 10 2.55 x 5
Post-market by (Cboe BZX)
2.54 +0.03 (+1.20%) 03/21/25 [NASDAQ]
2.45 x 10 2.55 x 5
Post-market 2.54 unch (unch) 16:13 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | LRMR | IKT | SAVA | ||
| Company | Larimar Therapeutics Inc | Inhibikase Therapeutics Inc | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.47 | 2.42 | 2.71 | ||
| High | 2.56 | 2.46 | 2.89 | ||
| Low | 2.44 | 2.36 | 2.71 | ||
| Last | 2.54 | 2.37 | 2.84 | ||
| Change | +0.03 | -0.05 | +0.08 | ||
| % Change | +1.20% | -2.07% | +2.90% | ||
| Volume | 655,300 | 112,800 | 1,661,800 | ||
| 20-Day Average Volume | 679,905 | 145,385 | 1,594,790 | ||
| Previous Close | 2.51 | 2.42 | 2.76 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 2.27 | 2.65 | ||
| 20-Day Raw Stochastic | 26.88% | 46.94% | 72.37% | ||
| 20-Day Relative Strength | 37.70% | 48.87% | 45.75% | ||
| Weighted Alpha | -69.81 | -11.62 | -51.01 | ||
| Today's Opinion | 100% Sell | 8% Buy | 40% Sell | ||
| Previous Opinion | 100% Sell | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.93% since 03/14/25 | +5.33% since 03/14/25 | +1.79% since 03/14/25 | ||
| Low | 2.29 on 03/18/25 | 2.24 on 03/17/25 | 2.65 on 03/19/25 | ||
| High | 2.64 on 03/17/25 | 2.58 on 03/20/25 | 3.05 on 03/18/25 | ||
| 1-Month | |||||
| %Chg | -20.38% since 02/21/25 | -20.20% since 02/21/25 | +11.37% since 02/21/25 | ||
| Low | 2.29 on 03/18/25 | 1.91 on 03/10/25 | 2.29 on 02/26/25 | ||
| High | 3.22 on 02/24/25 | 2.89 on 02/24/25 | 3.05 on 03/18/25 | ||
| 3-Month | |||||
| %Chg | -36.66% since 12/20/24 | -25.94% since 12/20/24 | +20.85% since 12/20/24 | ||
| Low | 2.29 on 03/18/25 | 1.90 on 01/31/25 | 2.25 on 02/07/25 | ||
| High | 4.27 on 01/03/25 | 3.49 on 01/02/25 | 3.18 on 01/07/25 | ||
| 6-Month | |||||
| %Chg | -64.07% since 09/20/24 | +97.50% since 09/20/24 | -90.46% since 09/20/24 | ||
| Low | 2.29 on 03/18/25 | 1.12 on 09/25/24 | 2.23 on 12/20/24 | ||
| High | 9.50 on 11/11/24 | 4.20 on 12/18/24 | 33.98 on 11/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 162,070 | 164,388 | 137,195 | ||
| Shares Outstanding, K | 63,807 | 69,362 | 48,308 | ||
| Annual Sales | 0 | 260,000 | 0 | ||
| Annual Net Income | -36,950,000 | -19,030,000 | -24,340,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -15,500,000 | -5,780,000 | -27,600,000 | ||
| 60-Month Beta | 0.99 | 1.04 | -1.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 10/30/24 | -0.65 on 11/14/24 | -0.57 on 03/03/25 | ||
| Latest Earnings Date | 03/27/25 | 03/26/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||